
Venkateshwar Jambula
Lead Market Researcher
3 min read
•Published on September 10, 2024
•For sophisticated investors leveraging intraday trading strategies, understanding the settlement cycle and the availability of profits is crucial for effective capital management. Recent regulations by the Securities and Exchange Board of India (Sebi) have introduced specific timelines for when intraday trading profits become accessible.
Sebi's mandate dictates that profits realized from intraday trades are not immediately available for withdrawal or reinvestment on the same trading day (T). Instead, these funds are typically unblocked and become accessible only after the market closes on the next working day (T+1).
This means that any capital gains from your intraday transactions on a given day will not be part of your usable trading balance until the settlement process for that day is complete on the subsequent trading day.
This regulatory framework directly impacts how you manage your trading capital throughout the day and across trading sessions.
Example Scenario:
Consider an investor who executes several intraday trades on a specific day, let's call it Transaction Day (T).
On Transaction Day (T), the gross profit from these trades is ₹23,400 (sale value) - ₹19,600 (purchase value) = ₹3,800. However, this ₹3,800 profit, along with the initial capital used, will not be fully released and available for initiating new trades until the end of the next working day (T+1).
Understanding the T+1 settlement is vital for:
PortoAI's advanced analytics and real-time data synthesis empower you to navigate these market mechanics with greater confidence. Our platform provides a clear view of your capital positions and potential cash flows, enabling more disciplined trading decisions. By integrating Sebi's settlement regulations into your strategy, you can optimize your capital allocation and mitigate potential liquidity risks, ensuring you maintain a competitive edge in the markets.
Blog
Explore our latest investment strategies and insights.
Stocks
Pine Labs' ₹3,900 crore IPO opened for subscription in India on November 7, 2025, featuring a fresh issue and an offer for sale. The issue has a price band of...
November 7, 2025
•5min
Stocks
Curis Lifesciences, an Indian pharmaceutical company, launched its Rs 27.5 crore SME IPO for public subscription on November 7, 2023. This offers investors an opportunity to participate in India's expanding...
November 7, 2025
•4min
Stocks
Lenskart's IPO, for India's largest eyewear retailer, was subscribed over 20 times on its final day, indicating robust investor interest in the Indian market. Despite strong demand, the Grey Market...
November 6, 2025
•4min
Stocks
The Securities and Exchange Board of India (Sebi) plans to overhaul its 30-year-old stock broker regulations in India, aiming to strengthen risk management and data protection. This review is targeted...
November 6, 2025
•5min